Gencove has developed a genetic testing program that enables users to access services such as genome sequencing without requiring access to a lab themselves.
New York Genome Center (NYGC) has officially launched its spinout Gencove, which has developed a genetic testing program that is accessed through a mobile app, according to GenomeWeb.
The company has obtained $1m in funding from Third Kind Venture Capital, Version One Ventures, Refactor Capital, SV Angel, Kresimir Penavic and Balaji Srinivasan.
Gencove has developed a genetic testing technology kit, available for approximately $60, that offers genome sequencing assay, ancestry and microbiome testing services. The results are delivered through a…
